Megakaryocyte colony-forming unit growth is enhanced by alemtuzumab: In vitro experiments and a case report of acquired amegakaryocytic thrombocytopenic purpura [1]

Leukemia

Volumn 20, Issue 9, 2006, Pages 1618-1619

  Doubek, M ^a   Koristek Z ^a   Havranova D ^a   Smardova L ^a   Mayer, J ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CYCLOSPORIN A; METHYLPREDNISOLONE;

ADULT; BIOASSAY; BONE MARROW BIOPSY; CASE REPORT; CELL GROWTH; COLONY FORMING UNIT; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FLOW CYTOMETRY; GROWTH STIMULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; LETTER; MEGAKARYOCYTE; MEGAKARYOPOIESIS; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; T CELL DEPLETION; THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; VIRUS REACTIVATION;

EID: 33747586722     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404337     Document Type: Letter

References (8)

1. Chakrabarti S, MacDonald D, Hale G, Holder K, Turner V, Czarnecka H et al. T-cell depletion with Campath-1H 'in the bag' for matched related allogeneic peripheral blood stem cell transplantation is associated with reduced graft-versus-host disease, rapid immune constitution and improved survival. Br J Haematol 2003; 121: 109-118.
2. Hale G, Jacobs P, Wood L, Fibbe WE, Barge R, Novitzky N et al. CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells. Bone Marrow Transplant 2000; 26: 69-76.
3. Gilleece MH, Dexter TM. Effect of Campath-1H antibody on human hematopoietic progenitors in vitro. Blood 1993; 82: 807-812.
4. Ho VT, Soiffer RJ. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 2001; 98: 3192-3204.
5. Nagler A, Condiotti R, Lubina A, Deutsch VR. Enhancement of megakaryocytopoiesis by Campath-1G-treated natural killer cells. Bone Marrow Transplant 1997; 20: 525-531.
6. Geissler D, Lu L, Bruno E, Yang HH, Broxmeyer HE, Hoffman R. The influence of T lymphocyte subsets and humoral factors on colony formation by human bone marrow and blood megakaryocyte progenitor cells in vitro. J Immunol 1986; 137: 2508-2513.
7. Monteiro JP, Benjamin A, Costa ES, Barcinski MA, Bonomo A. Normal hematopoiesis is maintained by activated bone marrow CD4+ T cells. Blood 2005; 105: 1484-1491.
8. Hoffman R. Acquired pure amegakaryocytic thrombocytopenic purpura. Semin Hematol 1991; 28: 303-312.